PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,400 | +80.1% | 222,819 | 0.0% | 0.00% | – |
| Q2 2023 | $36,877 | -83.1% | 222,819 | -0.5% | 0.00% | – |
| Q1 2023 | $218,457 | -49.8% | 223,829 | -46.5% | 0.00% | – |
| Q4 2022 | $435,404 | +80.7% | 418,658 | +100.0% | 0.00% | – |
| Q3 2022 | $241,000 | -38.4% | 209,329 | 0.0% | 0.00% | – |
| Q2 2022 | $391,000 | -39.6% | 209,329 | -2.0% | 0.00% | – |
| Q1 2022 | $647,000 | -9.6% | 213,499 | +12.7% | 0.00% | – |
| Q4 2021 | $716,000 | -26.9% | 189,387 | 0.0% | 0.00% | – |
| Q3 2021 | $979,000 | +50.4% | 189,387 | +11.3% | 0.00% | – |
| Q2 2021 | $651,000 | -72.4% | 170,087 | -81.5% | 0.00% | – |
| Q1 2021 | $2,357,000 | 0.0% | 917,247 | -2.7% | 0.00% | – |
| Q4 2020 | $2,357,000 | +23.2% | 942,822 | +2.0% | 0.00% | – |
| Q3 2020 | $1,913,000 | -33.1% | 924,369 | +0.1% | 0.00% | – |
| Q2 2020 | $2,861,000 | +35.3% | 923,058 | -0.4% | 0.00% | – |
| Q1 2020 | $2,114,000 | -40.8% | 927,220 | -6.0% | 0.00% | – |
| Q4 2019 | $3,572,000 | +7.9% | 986,703 | +1.6% | 0.00% | – |
| Q3 2019 | $3,312,000 | -31.2% | 971,245 | -5.1% | 0.00% | – |
| Q2 2019 | $4,812,000 | +56.8% | 1,023,895 | +11.8% | 0.00% | – |
| Q1 2019 | $3,068,000 | +27.3% | 915,915 | +1.0% | 0.00% | – |
| Q4 2018 | $2,411,000 | -52.6% | 906,570 | -0.3% | 0.00% | – |
| Q3 2018 | $5,090,000 | +34.2% | 909,144 | +21.7% | 0.00% | – |
| Q2 2018 | $3,792,000 | -4.9% | 747,250 | +27.8% | 0.00% | – |
| Q1 2018 | $3,987,000 | -0.6% | 584,649 | +10.0% | 0.00% | – |
| Q4 2017 | $4,012,000 | +34.7% | 531,516 | +2.8% | 0.00% | – |
| Q3 2017 | $2,978,000 | +25.3% | 517,052 | +10.1% | 0.00% | – |
| Q2 2017 | $2,377,000 | – | 469,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |